Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Bioartificial liver (BAL) support system has been proposed as potential treatment method for end‐stage liver diseases. We described an improved BAL system based on a choanoid fluidized bed bioreactor containing alginate–chitosan encapsulated primary porcine hepatocytes. The feasibility, safety, and efficiency of this device were estimated using an allogeneic fulminant hepatic failure (FHF) model. FHF was induced with intravenous administration of D‐galactosamine. Thirty FHF pigs were divided into three groups: (1) an FHF group which was only given intensive care; (2) a sham BAL group which was treated with the BAL system with empty encapsulation, and (3) a BAL group which was treated with the BAL system containing encapsulated freshly isolated primary porcine hepatocytes. The survival times and biochemical parameters of these animals were measured, and properties of the encapsulations and hepatocytes before and after perfusion were also evaluated. Compared to the two control groups, the BAL‐treated group had prolonged the survival time and decreased the blood lactate levels, blood glucose, and amino acids remained stable. No obvious ruptured beads or statistical decline in viability or function of encapsulated hepatocytes were observed. This new fluidized bed BAL system is safe and efficient. It may represent a feasible alternative in the treatment of liver failure. Biotechnol. Bioeng. 2011;108:2229–2236. © 2011 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioreactor design for tissue engineering
Pörtner, R., Nagel-Heyer, S., Goepfert, C., Adamietz, P., & Meenen, N. M. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.235 · Cited by 305
Cited by
Li, J., Zhang, L., Xin, J., Jiang, L., Zhang, T., Jin, L., Li, J., Zhou, P., Hao, S., Cao, H., et al. (2012) · Hepatology · doi:10.1002/hep.25722 · Cited by 116
“Within 2-4 days following the induction of FHF in animals, hepatocytes undergo massive necrosis with hemorrhages involving entire lobules, which results in death.(20,22) Thus, direct intraportal transfusion within this damaged environment may result in the proliferation and transdifferentiation of transplanted hBMSCs…”
BackgroundSelf-citationA decade of progress in liver regenerative medicine
Zhang, J., Zhao, X., Liang, L., Li, J., Demirci, U., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.027 · Cited by 111
Liver Tissue Engineering as an Emerging Alternative for Liver Disease Treatment
Mirdamadi, E. S., Kalhori, D., Zakeri, N., Azarpira, N., & Solati-Hashjin, M. (2020) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2019.0233 · Cited by 57
Bioartificial livers: a review of their design and manufacture
Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6e86 · Cited by 24
“Li et al [19] developed a BAL system based on a fluidized bed bioreactor using microencapsulated primary porcine hepatocytes and successfully extended the survival time of FHF pigs.”
Effect of plasma components on the stability and permeability of microcapsule
Chen, L., Zhang, Y., Li, S., Wang, X., Li, N., Wang, Y., Guo, X., Zhao, S., Yu, W., Sun, G., et al. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34907 · Cited by 10
Self-citationLu, J., Zhu, D., & Li, L. (2022) · The International Journal of Artificial Organs · doi:10.1177/03913988211066502 · Cited by 3
Self-citation
Metadata
- Authors
- Lv, G., Zhao, L., Zhang, A., Du, W., Chen, Y., Yu, C., Pan, X., Zhang, Y., Song, T., Xu, J., Chen, Y., & Li, L.
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2011-04-14
- Volume
- 108
- Issue
- 9
- Pages
- 2229-2236
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2139348644
- Cited by
- 47
- References
- 1
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.